Gravcef S 1000mg/500mg Injection
Marketer
Gravion Life Sciences
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Gravcef S 1000mg/500mg Injection
Cefixime and Sulbactam injection (1000mg/500mg) is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and halting infection spread. Administration must always be overseen by a qualified medical practitioner. Complete the prescribed dosage; skipping doses is discouraged. Premature cessation may compromise treatment effectiveness. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and digestive upset. Report any worsening side effects immediately. Seek immediate medical attention for allergic reactions (e.g., skin rashes, itching, swelling, breathing difficulties). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require physician consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally safe for driving, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration are crucial for optimal recovery. Your doctor may order blood tests and other assessments to monitor the medication's effects.
Primary Ingredients of Gravcef S 1000mg/500mg Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Gravcef S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Gravcef S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Gravcef S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Gravcef S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Gravcef S 1000mg/500mg Injection works:
Gravcef S 1000mg/500mg Injection combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between alcohol ingestion and Gravcef S 1000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Gravcef S (1000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Gravcef S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Gravcef S 1000mg/500mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving is discouraged should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Gravcef S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable medication Gravcef S (1000mg/500mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Gravcef S (1000mg/500mg) injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Gravcef S 1000mg/500mg Injection :
Should you forget a dose of Gravcef S 1000mg/500mg Injection, seek your physician's advice.
Facts to Know About Gravcef S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently